Dr Gan Liangying shares on how to interpret NT-proBNP in CKD (Chronic Kidney Diseases) values in the cardiac health management of CKD patients with HF.
ACC 2025 Spotlight: DROP-Asian ACS Interim Analysis Highlights Regional Gains in NSTEMI Care
Clinical Application NT-proBNP in CKD (Chronic Kidney Diseases) Patients with Cardiovascular Diseases
15 December 2022
KEY TAKEAWAYS
- CKD complicated with CVD, especially HF death, is the main cause of death in patients with chronic kidney disease.
- NT-proBNP level stratification can effectively predict the risk of CKD complicated with HF, cardiovascular mortality and all-cause mortality in patients with CKD stage 1-5.
- The eGFR factor needs to be balanced for risk prediction for CKD patients using stratification cut-off value of NT-proBNP level.
- NT-proBNP level stratification can not only predict the degree of cardiac function impairment (volume load), but also predict the renal function.
